SUTRO BIOPHARMA, INC.·4

Mar 3, 6:48 PM ET

Chung Jane 4

4 · SUTRO BIOPHARMA, INC. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-03-01
Chung Jane
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-01+68814,579 total
  • Exercise/Conversion

    Common Stock

    2026-03-01+2,50017,079 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-01$20.47/sh1,271$26,01715,808 total
  • Exercise/Conversion

    Common Stock

    2026-03-02+7,75023,558 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-02$20.55/sh2,779$57,10820,779 total
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    [F2][F3]
    2026-03-01688688 total
    Exp: 2027-03-01Common Stock (688 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    [F2][F4]
    2026-03-012,5005,000 total
    Exp: 2028-03-01Common Stock (2,500 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    [F2][F5]
    2026-03-027,75023,250 total
    Exp: 2029-03-02Common Stock (7,750 underlying)
  • Award

    Restricted Stock Units (RSUs)

    [F2][F6]
    2026-03-02+40,00040,000 total
    Exp: 2030-03-01Common Stock (40,000 underlying)
  • Award

    Stock Option (right to buy)

    [F7]
    2026-03-02+175,000175,000 total
    Exercise: $20.55Exp: 2036-03-02Common Stock (175,000 underlying)
Footnotes (7)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
  • [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
  • [F3]The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2024, subject to continued service through each vesting date.
  • [F4]The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 1, 2025, subject to continued service through each vesting date.
  • [F5]The RSUs vested or vest as to 1/4 of the total award annually, with the first tranche vested on March 2, 2026, subject to continued service through each vesting date.
  • [F6]The RSUs shall vest as to 1/4 of the total award annually, with the first tranche vesting on March 1, 2027, subject to continued service through each vesting date.
  • [F7]1/48 of the total option award shall vest monthly, subject to the reporting person's continued service through each vesting date, with the first tranche vesting on April 1, 2026.
Signature
/s/ David Pauling as attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    form4-03032026_110347.xmlPrimary